The markets opened up slightly higher, but pulled back by 10:00 AM ET, and was, more or less, flat. Now, the Trump administration is expected to reveal its full budget plan today, and traders will be focused on the details of the plan for any indication on which sectors it may affect. However, that’s a wait and see game. There are some stocks moving due to company-specific news, and here are some small-cap stocks to watch today.
Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares were up over 70% at 10:00 AM ET, after the company and RedZone (a subsidiary company of Helios and Matheson Analytics) , the creator of the RedZone Map navigation app, acquired global licensing rights to IsItYou’s facial recognition technology for integration with RedZone Map. That said, RedZone is planning to integrate the app’s artificial intelligence (AI) technology and real-time crime database with IsItYou’s facial recognition technology, which could potentially grow Helios and Matheson and RedZone’s business and earnings.
Check out HMNY on the 5-minute chart:
EnteroMedics Inc (NASDAQ: ETRM) was up over 14% by 10:15 AM ET, following the company’s announcement of its acquisition of the Gastric Vest System through its acquisition of BarioSurg Inc. The acquisition could expand the company’s business, which primarily focuses on the development of medical devices treating obesity, metabolic diseases and other gastrointestinal disorders. The Gastric Vest System is currently being studied for weight loss in morbidly obese patients, and helps to diversify the company’s medical devices portfolio.
Take a look at ETRM on the 5-minute chart below.
ETRM gapped up over 30%, and hit a high of $6.44, before pulling back below the $5.50 area. That said, one key area to watch is the $5 level.
Sonus Networks Inc (NASDAQ: SONS) shares were up over 6% at 10:20 AM ET, after the company and GENBAND, one of the leading providers of carrier and enterprise network transformation and real-time communications solutions, announced a definitive agreement to merge. SONS and GENBAND shareholders would each own around 50% of the newly formed company.
Take a look at SONS on the 15-minute chart below:
Cerus Corporation (NASDAQ: CERS) was down over 20% shortly after 10:00 AM ET, following the company’s announcement of its business update. Cerus Corp announced it received notification of a U.S. supply shortage of platelet additive solution (PAS) manufactured and sold by Fesenius Kabi, which was due to an unforeseen delay in the U.S. FDA’s approval of a plastic component used in the manufacturing of the PAS containers. This could impact certain U.S. blood centers using this product, and consequently, Cerus lowered its guidance range to $38M to $46M, compared to its prior guidance range of $43M to $48M.
Check out CERS on the daily chart:
TG Therapeutics Inc (NASDAQ: TGTX) announced that the independent Data Safety Monitoring Board of the UNITY-CLL Phase III trial successfully completed a pre-specified interim analysis, assessing the contribution of TG-1101 and TGR-1202. According to the company,
- “Contribution of single agents in the combination regimen successfully established pursuant to the UNITY-CLL Special Protocol Assessment; DSMB recommends no further enrollment to single agent arms.
- DSMB reviewed updated safety data from more than 270 patients, finding no safety concerns and recommended continuation of enrollment without modification.”
TGTX was up over 6% by 10:30 AM ET, and here’s a look at the 5-minute chart: